Vicapsys Life Sciences (OTCMKTS:VICP) Stock Price Down 58.3% – Here’s What Happened

Vicapsys Life Sciences, Inc. (OTCMKTS:VICP)’s stock price traded down 58.3% during mid-day trading on Tuesday . The company traded as low as $1.25 and last traded at $1.25. 500 shares changed hands during mid-day trading, an increase of 32% from the average session volume of 380 shares. The stock had previously closed at $3.00.

Vicapsys Life Sciences Trading Down 58.3 %

The firm has a market capitalization of $40.46 million, a price-to-earnings ratio of -31.25 and a beta of -3.93. The firm has a fifty day moving average price of $1.75 and a 200 day moving average price of $2.03.

Vicapsys Life Sciences (OTCMKTS:VICP) last announced its earnings results on Friday, January 10th. The company reported ($0.01) earnings per share for the quarter.

Vicapsys Life Sciences Company Profile

Vicapsys Life Sciences, Inc focuses on the development and commercialization of VICAPSYN, a proprietary product. The company’s product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers.